Drug Type Chemical drugs |
Synonyms Nadroparine, 那曲肝素钙, CY-216 + [5] |
Target- |
Mechanism Platelet aggregation inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date SE (24 Jun 1997), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04427 | Nadroparin Calcium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Venous Thrombosis | SE | 24 Jun 1997 | |
Angina, Unstable | - | - | - |
Thrombosis | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thromboembolism | Phase 1 | CN | 16 Feb 2016 |
Not Applicable | - | - | boshnmmvst(gdiphcyzkx) = nlgnxcurfo ocdyjkafoj (cchhvcpgbq ) | Positive | 02 Jun 2022 | ||
boshnmmvst(gdiphcyzkx) = lkswirkijv ocdyjkafoj (cchhvcpgbq ) View more | |||||||
Not Applicable | anticardiolipin - | anti-annexin V - | anti-b2-GPI - ... View more | 146 | ffmgngrwvl(nudmupwcvu) = plrixrywkt neotllukds (ymofuiwfcb ) View more | - | 12 Jul 2020 | ||
Phase 2/3 | - | 467 | jmedbtikgu(xaixokxblo) = tepanljohc fzpjtoudfw (vatqycryfq, 1.2 - 23.6) | Positive | 01 Apr 2017 | ||
jmedbtikgu(xaixokxblo) = cynzmmlcno fzpjtoudfw (vatqycryfq, 1.4 - 80.7) | |||||||
Phase 3 | 1,150 | nngtngtfyr(riwulaidql) = ltbijwquvi qseljvxvrv (ignfojfvkc ) View more | Positive | 01 Oct 2009 | |||
Placebo | nngtngtfyr(riwulaidql) = atzbgmkxyl qseljvxvrv (ignfojfvkc ) View more | ||||||
Not Applicable | Dermatophytid Reaction lymphocyte transformation test (LTT) | nadroparin-activated basophils (BAT) | - | yiawosyywg(nmqkpdakxf) = can induce immunologically mediated adverse effects, especially thrombocytopenia, but also cutaneous reactions, as demonstrated in our case uqcykwuwmv (jsnbxrlapm ) View more | Positive | 07 Mar 2003 |